Patient-related factors r p value Infusion-related factors r p value
Age 0.231 0.071 Dose -0.113 0.358
Gender 0.226 0.077 Dosing regimen 0.263* 0.039
Presence of one or more risk factors 0.243* 0.029 Course duration (days) 0.113 0.503
Primary Immunodeficiency -0.442** 0.000 Infusion hours (actual) -0.111 0.826
Auto-immunity 0.203 0.113 Infusion hours(intended) 0.116 0.370
Nephrotoxic drugs 0.389** 0.002 Infusion rate 0.112 0.317
Infection -0.175 0.174 IVIG Preparation 0.376** 0.003
Allergy 0.313* 0.013 FinalĀ  infusion diagnosis 0.269* 0.035
Pre-existing renal insufficiency -0.062 0.633 FDA approval -0.384** 0.002
*Correlation is significant at 0.05 levels (2-tailed)
**Correlation is significant at 0.01 levels (2-tailed)
Table 2: General incidence of adverse events following IVIG and its correlation to patient-related and infusion-related parameters.